Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD.

Scientific reports·2020

Same author

Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium.

JCI insight·2020

Same author

Integrated proteogenomic approach identifying a protein signature of COPD and a new splice variant of SORBS1.

Thorax·2020

Same author

IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids.

Allergy·2019

Same author

Nasal gene expression changes with inhaled corticosteroid treatment in asthma.

Allergy·2019

Same author

Differential lung tissue gene expression in males and females: implications for the susceptibility to develop COPD.

The European respiratory journal·2019

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Increased systemic inflammation is a risk factor for COPD exacerbations.

Karin H Groenewegen¹, Dirkje S Postma, Wim C J Hop

¹Department of Respiratory Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, the Netherlands. ksi@lung.azm.nl

|January 17, 2008

Summary

Elevated systemic inflammation, particularly higher fibrinogen levels, and reduced lung function predict more frequent COPD exacerbations. Targeting inflammation may help manage COPD patients and decrease exacerbation frequency.

More Related Videos

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Related Experiment Videos

Last Updated: Jul 8, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

Area of Science:

Pulmonary Medicine
Inflammation Research
Chronic Disease Management

Background:

Chronic Obstructive Pulmonary Disease (COPD) is marked by exacerbations, which involve increased local and systemic inflammation.
Understanding predictive factors for these exacerbations is crucial for patient management.

Purpose of the Study:

To investigate if elevated systemic inflammation at baseline predicts acute exacerbations in COPD patients.
To identify specific inflammatory markers and lung function parameters associated with exacerbation risk.

Main Methods:

A cohort of COPD patients was followed prospectively for one year to record moderate and severe exacerbations.
Baseline measurements included lung function (FEV1, FVC, FRC, Dlco) and systemic inflammation markers (CRP, fibrinogen, LBP, TNF-alpha, sTNF-Rs).

Main Results:

Higher initial fibrinogen levels and lower FEV1 independently predicted increased rates of both moderate and severe exacerbations.
Lower Dlco and a history of severe exacerbations predicted severe exacerbations, while a history of moderate exacerbations predicted moderate exacerbations.

Conclusions:

Systemic inflammation, specifically elevated fibrinogen, is an independent risk factor for COPD exacerbations, alongside impaired lung function.
Reducing systemic inflammation could offer new therapeutic strategies to decrease the exacerbation burden in COPD.